Passage Bio (NASDAQ:PASG) just reported results for the fourth quarter of 2023.
- Passage Bio reported earnings per share of -30 cents. This was above the analyst estimate for EPS of -40 cents.
- The company did not report any revenue for the quarter.
Source: iQoncept / Shutterstock
Passage Bio (NASDAQ:PASG) just reported results for the fourth quarter of 2023.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/pasg-stock-earnings-passage-bio-for-q4-of-2023/.
©2025 InvestorPlace Media, LLC